Supportive care needs and distress in patients with non-melanoma skin cancer: Nothing to worry about?

Körner, Annett; Garland, Rosalind; Czajkowska, Zofia; Coroiu, Adina; Khanna, Manish

doi:10.1016/j.ejon.2015.07.006

Cited by 37 publications

(45 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…41 Other quantitative studies have also shown that patients with keratinocyte carcinoma experience anxiety and worry about future skin cancers, 42 and have unmet needs regarding the health system and information-related matters. 8 The overall methodological quality of the included studies was good, although there was general poor reflexivity. Providing an overall score for the level of confidence in qualitative review findings is a relatively new development, 19,43 and draws upon the concepts of dependability (established using a set of critical appraisal questions) and credibility (ranked according to the 'goodness of fit' between the author's interpretation and the original data).…”

Section: Discussionmentioning

confidence: 97%

“…Knowledge about recognizing signs of skin cancer is particularly important as 44% of patients with a keratinocyte carcinoma will develop additional lesions within 3 years and there is a 2·8% risk of developing a second melanoma after 5 years and a 3·6% risk after 10 years . Other quantitative studies have also shown that patients with keratinocyte carcinoma experience anxiety and worry about future skin cancers, and have unmet needs regarding the health system and information‐related matters …”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

The needs and experiences of patients with skin cancer: a qualitative systematic review with metasynthesis

2017

View full text Add to dashboard Cite

Skin cancer incidence is increasing worldwide. This is an update of a previous review published in 2010 that identified only two studies and found that the needs and experiences of individuals with skin cancer were under-researched. Our objective was to undertake a qualitative systematic review of the needs and experiences of people with a diagnosis of skin cancer. To update the previous review, the following databases were searched from 2010 to 30 November 2015: CINAHL PsycINFO, Medline and Embase. The methodological quality of the studies was assessed using the Joanna Briggs Institute Qualitative Assessment Review Instrument. The qualitative research findings were synthesized using a pragmatic meta-aggregative approach. A total of 14 studies (16 papers) were included. Only three studies included patients with keratinocyte carcinoma. Overall, 15 categories were identified and these resulted in four overarching synthesized findings (SFs) from diagnosis (SF1), throughout treatment (SF2) and follow-up (SF3), and then a fourth SF (SF4) that addressed patients' satisfaction with their care and their relationship with healthcare professionals. Despite the fact that patients with keratinocyte carcinoma and melanoma can have a very different prognosis, they also share similar needs and concerns especially around the time of diagnosis and follow-up/surveillance for new lesions. Healthcare professionals working with patients with skin cancer need to understand their psychosocial concerns and their information needs in order to design services appropriately. Future studies need to consider patients with keratinocyte carcinoma in addition to patients with melanoma.

show abstract

Section: Discussionmentioning

confidence: 97%

Section: Discussionmentioning

confidence: 99%

The needs and experiences of patients with skin cancer: a qualitative systematic review with metasynthesis

2017

View full text Add to dashboard Cite

show abstract

“…There were publications on comorbidities in SC patients, 113 HRQoL after treatment [118][119][120][121][122][123][124][125][126] and many studies dedicated to different aspects of QoL in different populations of SC patients including studies on behaviour modification, 169,170 predictors of QoL, 171,172 predictors of survival, 173,174 supportive care needs, 175,176 coping strategies 177 and fear of cancer recurrence. 178 Many HRQoL tools have been used in SC patients, with a range of frequency of use.…”

Section: Exclusion Criteriamentioning

confidence: 99%

Quality of life measurement in skin cancer patients: literature review and position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes, Melanoma and Non‐Melanoma Skin Cancer

Chernyshov

Lallas

Tómas-Aragonés

et al. 2019

Acad Dermatol Venereol

View full text Add to dashboard Cite

The European Academy of Dermatology and Venereology (EADV) Task Forces (TFs) on Quality of Life (QoL) and Patient Oriented Outcomes, Melanoma and Non-Melanoma Skin Cancer (NMSC) present a review of the literature and position statement on health-related (HR) QoL assessment in skin cancer patients. A literature search was carried out to identify publications since 1980 that included information about the impact of SC on QoL. Generic, dermatology-specific, cancer-specific, SC-specific, facial SC-specific, NMSC-specific, basal cell carcinoma-specific and melanoma-specific QoL questionnaires have been used to assess HRQoL in SC patients. HRQoL was assessed in the context of creation and validation of the HRQoL instruments, clinical trials, comparison of QoL in SC and other cancers, other diseases or controls, HRQoL assessment after treatment, comorbidities, behaviour modification, predictors of QoL and survival, supportive care needs, coping strategies and fear of cancer recurrence. The most widely used instruments for HRQoL assessment in SC patients are the European Organisation for Research and Treatment of Cancer Core Questionnaire (EORTC QLQ-C30), the Functional Assessment of Cancer Therapy-Melanoma (FACT-M), Skin Cancer Index (SCI), ShortForm 36 Item Health Survey (SF-36) and the Dermatology Life Quality Index (DLQI). The TFs recommend the use of the cancer-specific EORTC QLQ-C30, especially in late stages of disease, and the melanoma-specific FACT-M and SCspecific SCI questionnaires. These instruments have been well validated and used in several studies. Other HRQoL instruments, also with good basic validation, are not currently recommended because the experience of their use is too limited. Dermatology-specific HRQoL instruments can be used to assess the impact of skin-related problems in SC. The

show abstract

“…Es frecuente que las lesiones dérmicas les lleven a un cierto retraimiento social por la apariencia física que provocan las lesiones. En algunos casos, donde la persona tiene otras enfermedades, puede haber un cierto rechazo a la cirugía o a tomar más medicaciones, lo que nos debe llevar a explorar este tipo de ideas 19 . En otros casos, las dificultades cognitivas relacionadas con la demencia pueden requerir que el especialista se tome su tiempo para poder explicar el alcance de la lesión y las consecuencias de las alternativas terapéuticas 20 .…”

Section: Tabla 2 Prioridades Vitales De Las Personas Según El Grupo unclassified

Repercusión emocional del cáncer de piel y el envejecimiento cutáneo

Valladolid¹

2017

Más Dermatol

View full text Add to dashboard Cite

Supportive care needs and distress in patients with non-melanoma skin cancer: Nothing to worry about?

Cited by 37 publications

References 43 publications

The needs and experiences of patients with skin cancer: a qualitative systematic review with metasynthesis

The needs and experiences of patients with skin cancer: a qualitative systematic review with metasynthesis

Quality of life measurement in skin cancer patients: literature review and position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes, Melanoma and Non‐Melanoma Skin Cancer

Repercusión emocional del cáncer de piel y el envejecimiento cutáneo

Contact Info

Product

Resources

About